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Abstract
Rationale: Anaerobic bacteria are present in large numbers in
the airways of people with cystic fibrosis (PWCF). In the gut,
anaerobes produce short-chain fatty acids (SCFAs) that modulate
immune and inflammatory processes.
Objectives: To investigate the capacity of anaerobes to contribute
to cystic fibrosis (CF) airway pathogenesis via SCFAs.
Methods: Samples of 109 PWCF were processed using anaerobic
microbiological culture with bacteria present identified by 16S
RNA sequencing. SCFA levels in anaerobic supernatants and
bronchoalveolar lavage (BAL) were determined by gas
chromatography. The mRNA and/or protein expression of
two SCFA receptors, GPR41 and GPR43, in CF and non-CF
bronchial brushings and 16HBE14o2 and CFBE41o2 cells
were evaluated using reverse transcription polymerase chain
reaction, Western blot analysis, laser scanning cytometry,
and confocal microscopy. SCFA-induced IL-8 secretion
was monitored by ELISA.
Measurements and Main Results: Fifty-seven (52.3%) of 109
PWCF were anaerobe positive. Prevalence increased with age,
from 33.3% to 57.7% in PWCF younger (n = 24) and older (n = 85)
than 6 years of age. All evaluated anaerobes produced millimolar
concentrations of SCFAs, including acetic, propionic, and butyric
acids. SCFA levels were higher in BAL samples of adults than in those
of children. GPR41 levels were elevated in CFBE41o2 versus
16HBE14o2 cells; CF versus non-CF bronchial brushings; and
16HBE14o2 cells after treatment with cystic fibrosis transmembrane
conductance regulator inhibitor CFTR(inh)-172, CF BAL, or
inducers of endoplasmic reticulum stress. SCFAs induced a dose-
dependent and pertussis toxin–sensitive IL-8 response in bronchial
epithelial cells, with a higher production of IL-8 in CFBE41o2 than
in 16HBE14o2 cells.
Conclusions: This study illustrates that SCFAs contribute to
excessive production of IL-8 in CF airways colonized with anaerobes
via up-regulated GPR41.
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The main cause of morbidity and mortality
in cystic fibrosis (CF) is respiratory failure
resulting from persistent microbial infection
and neutrophil-dominated inflammation
(1, 2). Bacteria such as Pseudomonas
aeruginosa, Staphylococcus aureus,
Haemophilus influenzae, and Burkholderia
cepacia complex have been recognized as
key pathogens in CF airway infection (3).
The detection of bacterial pathogens in CF
depends mostly on routine aerobic culture
techniques. Consequently, the prevalence
of anaerobic and other fastidious bacteria
has remained largely understudied.
With the implementation of enhanced
culture-dependent and culture-independent
molecular diagnostics–based techniques,
interest in the prevalence and potential
pathogenic role of anaerobes has been
sparked (4–6).
Anaerobic bacteria are present in the
airways of 66–91% people with CF (PWCF)
(7, 8) in numbers equal to those of
P. aeruginosa, a well-established pathogen
in the CF airways (3, 7). Studies exploring
the role of anaerobes have failed to show a
direct impact on airway function in CF
(7, 8). However, more recent studies have
associated decreasing CF airway microbial
diversity, to which anaerobic bacteria
contribute, with poorer lung function
(9–11). Contrary to this, Prevotella
intermedia was shown to induce a
humoral immune response in PWCF and
to mediate an influx of neutrophils and
macrophages, thereby increasing CF
airway inflammation (12). Furthermore,
anaerobes belonging to the oropharyngeal
flora have been shown to enhance the
virulence of P. aeruginosa in a number
of infection models (13–17).
Anaerobic bacteria comprise an
integral part of the normal gut microflora,
where they produce copious amounts of
short-chain fatty acids (SCFAs), including
acetic, propionic, and butyric acids (18).
In addition to their role as fuel for intestinal
epithelial cells, SCFAs modulate various
processes, including cell proliferation and
differentiation, hormone secretion,
metabolic homeostasis, and modulation
of immune and inflammatory responses
(18–23), by binding to the recently
deorphanized G protein–coupled
receptors, GPR41 (also called free fatty
acid receptor 3 or FFAR3) and GPR43
(FFAR2) and by the inhibition of histone
deacetylase (HDAC) (24–26).
In the present study, we investigated
the capacity of anaerobic bacteria, found
in the CF airways, to induce an
inflammatory response by the production
of SCFAs. The results revealed that these
anaerobes produce copious amounts of
SCFAs that were also present in the
bronchoalveolar lavage (BAL) of PWCF.
SCFAs induced a dose-dependent and
pertussis toxin (PTX)–sensitive IL-8
response in bronchial epithelium that was
higher in CF than in normal bronchial
epithelial cells. This effect coincided with
increased GPR41 expression in CF
compared with normal bronchial epithelial
cells that was intrinsically driven by lack
of cystic fibrosis transmembrane
conductance regulator (CFTR) activity
and endoplasmic reticulum (ER) stress, in
addition to the proinflammatory milieu
of the CF airways.
Some of the results of this study
were previously reported in the form of
abstracts (27–29).
Methods
Comprehensive details on all methods,
including quantification of SCFAs,
quantification of SCFA receptors, CF and
non-CF bronchial epithelial cell culture and
treatments, and measurement of IL-8, are
provided in the online supplement.
Study Population
A total of 109 PWCF (age range, 0–61 yr;
mean age, 20.76 12.1 yr; 65 males, 44
females) were recruited into this study.
Seventy-three PWCF were attending
Beaumont Hospital, Dublin, Ireland (age
range, 18–61 yr; mean age, 27.46 8.2 yr;
44 males, 29 females); 24 were attending
Our Lady’s Children’s Hospital, Crumlin,
Ireland (age range, 0–6 yr; mean age, 3.56
1.6 yr; 11 males, 13 females); and 12 were
attending Temple Street Children’s
University Hospital, Dublin, Ireland (age
range, 7–17 yr; mean age, 14.66 2.4 yr;
10 males, 2 females). CF was confirmed by
sweat testing and/or genotyping. Only
clinically stable PWCF were included in
this study. Clinical stability was defined as
no change in symptoms, FEV1 within 10%
of best value in the previous 6 months,
and no new antibiotics started. Full
informed consent was obtained from
all participants or their parents before
the collection of samples, and ethical
approval was obtained from Beaumont
Hospital, Our Lady’s Children’s Hospital,
and Temple Street Children’s University
Hospital institutional review boards.
Collection and Processing of Sputum
and BAL
Spontaneously expectorated sputum was
collected in a sterile container that was
placed into an Anaerogen Compact
anaerobic pouch (Thermo Fisher Scientific,
Waltham, MA) and immediately
transported to an anaerobic cabinet for
further processing. BAL samples were
obtained from individuals undergoing
diagnostic or therapeutic fiberoptic
At a Glance Commentary
Scientific Knowledge on the
Subject: A large number of culture-
dependent and culture-independent
studies have revealed a significant
anaerobic bioburden in cystic fibrosis
(CF) airways; however, the role of
anaerobic bacteria in the pathogenesis
of infection and inflammation in
the CF airways remains largely
underexplored.
What This Study Adds to the
Field: In the present study, we
demonstrate a high prevalence of
anaerobes in the airways of people with
CF and show that this prevalence
increases with age. Short-chain fatty
acids (SCFAs) were secreted by
anaerobic bacteria in vitro and were
also detected in vivo in CF
bronchoalveolar lavage. SCFAs induced
a significant IL-8 response in bronchial
epithelial cells that was more
pronounced in CF than in normal
bronchial epithelium. Two receptors
for SCFAs, GPR41 and GPR43, were
expressed in bronchial epithelial cells.
However, only GPR41 was upregulated
in CF compared with normal airway
epithelium in vitro and in vivo.
GPR41 upregulation was intrinsically
driven by the lack of cystic fibrosis
transmembrane conductance regulator
activity and endoplasmic reticulum
stress and was further corroborated by
inflammatory stimuli. This study
provides novel insight into the
pathophysiological role of anaerobic
bacteria in the CF airways.
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bronchoscopy as part of routine care.
In adults, 60 ml of sterile 0.9% NaCl
was instilled into the right or left
subsegmental bronchi. In children, flexible
fiberoptic bronchoscopy was performed
via a laryngeal airway mask. To prevent
upper airway contamination, suction was
not performed until the tip of the
bronchoscope was past the carina. During
the procedure, 1 ml/kg of sterile 0.9%
NaCl was instilled twice in the right
middle lobe and twice in the lingula, and
all four samples were pooled. BAL
intended for anaerobic bacterial isolation
and identification was handled as
described above for sputum, and BAL
samples intended for SCFA determination
were filtered through gauze and
centrifuged at 5003 g for 10 minutes at
48C. The microbiological culture and
identification of bacteria in sputum and
BAL were performed as described
previously (7).
Bronchial Brushing Sample Collection
All patients (control subjects and PWCF)
were undergoing diagnostic or therapeutic
fiberoptic bronchoscopy as part of
routine care. Bronchial brushings were
recovered as previously described (30).
Statistical Analysis
Data were analyzed with GraphPad Prism
4.0 software (GraphPad Software, San
Diego, CA). Unless stated otherwise, all data
are presented as mean6 SEM and are
representative of at least three independent
experiments. Normal data were compared
using Student’s t test; nonnormal data were
compared by Mann-Whitney U test; and,
where appropriate, analysis of variance was
performed. Differences were considered
significant at P, 0.05.
Results
Anaerobic Bacteria Are Present in a
High Percentage of PWCF
To determine the prevalence of anaerobic
bacteria in the CF airways, 80 sputum
and 29 BAL samples of 109 PWCF were
collected and analyzed (one sample per
patient). The presence of at least one
obligate anaerobe was found in 57 (52.3%)
of 109 analyzed samples. The most
frequently detected obligate anaerobes
belonged to the genera Prevotella (35.8%),
Actinomyces (16.5%), Veillonella (8.3%),
and Fusobacterium (5.5%) (see Table E1
in the online supplement). The most
commonly occurring aerobes (facultative
anaerobes) belonged to the genera
Pseudomonas (44.0%), Staphylococcus
(41.3%), and Streptococcus (40.4%), the
latter including S. anginosus, S. constellatus,
S. intermedius, S. parasanguinis, and
S. sanguinis. The prevalence of obligate
anaerobes was greater than that of
P. aeruginosa (43.2%). Higher prevalence
of anaerobes was observed in PWCF older
than 6 years of age (57.7%; n = 85; mean
age, 25.66 8.9 yr; 54 males and 31 females)
than in PWCF younger than 6 years of
age (33.3%; n = 24; mean age, 3.56 1.6 yr;
11 males and 13 females) (Figure 1A),
demonstrating that the anaerobic
prevalence increases with age. On the
basis of these data, four representative
obligate anaerobes and one facultative





Selected Anaerobic Strains Secrete
Copious Amounts of SCFAs In Vitro
To investigate whether anaerobic bacteria
found in the CF airway secrete SCFAs,
bacterial supernatants from five
representative species grown under
anaerobic conditions were collected and
analyzed using gas chromatography.
American Type Culture Collection and
patient isolated strains of all selected
species secreted a variety of SCFAs in
millimolar concentrations (Figure 1B). Each
individual species had its own secretion
profile, which was identical for the
American Type Culture Collection and
patient isolate strains. For example, whereas
A. odontolyticus and S. sanguinis secreted
acetic acid, V. parvula and F. nucleatum
displayed more complex SCFA secretomes
consisting of acetic and propionic acid and
acetic, propionic, and butyric acids,
respectively. P. melaninogenica, produced
the highest number of SCFAs, including
acetic, i-butyric, 2-methylbutyric, and
i-valeric acids, albeit in lower
concentrations. Of note, P. aeruginosa
grown under anaerobic or aerobic
conditions did not secrete any SCFAs
(data not shown). These data suggest that
anaerobic bacteria found in the CF airway
produce copious amounts of SCFAs.
SCFAs Are Present in the Airways of
PWCF and Elevated in Adults
Compared with Children
To investigate whether anaerobes produce
SCFAs in the CF airway in vivo, BAL
samples of adults (n = 11; mean age, 29.26
9.3 yr; 3 males and 8 females) and children
with CF (n = 7; mean age, 4.06 2.2 yr;
2 males and 5 females) were collected and
analyzed using gas chromatography. Six
SCFAs detected in bacterial supernatants
were also observed in the micromolar
concentration range in BAL samples of
adult PWCF (Figure 1C). A significant
increase in acetic acid (P, 0.001) was
observed in BAL samples of adult PWCF
compared with children with CF. Similarly,
propionic and i-butyric acids were also
elevated, but the difference was not
statistically significant. These results
illustrate that SCFAs are present in the
airways of PWCF and are elevated in adult
PWCF compared with children with CF.
IL-8 Is Elevated in BAL of Adults
Compared with Children with CF and
Correlates with Acetic Acid
IL-8 is an inflammatory marker in the
airways of PWCF that mediates neutrophil
trafficking to the bronchial lumen (31). As
evaluated with an IL-8 ELISA, IL-8 was
markedly increased in BAL samples of
adult PWCF (n = 10; mean age, 30.16 9.7
yr; 3 males and 7 females) compared with
children with CF (n = 6; mean age, 4.56
1.9 yr; 2 males and 4 females) (Figure 1D).
A correlation analysis was performed to
investigate whether this phenomenon was
associated with SCFA levels in CF BAL.
IL-8 levels displayed a strong correlation
with acetic acid in BAL samples of children
and adults with CF (n = 16; r2 = 0.6409;
P = 0.002) (Figure 1E). Similarly, a
significant correlation was also observed
between IL-8 and acetic acid in BAL
samples of adult PWCF (n = 10; r2 = 0.4200;
P = 0.0427). No significant correlation
between IL-8 and other SCFAs in CF BAL
was observed (data not shown). Collectively,
these results showcase that elevated IL-8
levels in CF BAL are associated with high
levels of acetic acid in BAL.
Anaerobic Supernatants Induce an
Inflammatory Response in CF
Epithelial Cells
CFBE41o2 cells were treated with
supernatants from representative species
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and monitored for IL-8 secretion using
ELISA. All five strains induced a dose- and
PTX-dependent IL-8 response in
CFBE41o2 cells (Figure 2 and Figures E1
and E2). The highest IL-8 response was
observed with V. parvula and F. nucleatum
supernatants, which were shown to produce
high amounts of acetic, propionic, and
butyric acids. Interestingly, the IL-8
response induced by V. parvula and
F. nucleatum was equal to or greater
than that induced by the major CF
pathogens S. aureus and P. aeruginosa.
When CFBE41o2 cells were treated with
S. sanguinis or A. odontolyticus, which
secreted acetic acid only, a less pronounced
IL-8 response was observed and higher
concentrations of bacterial supernatant
(5% and 10%) were needed to achieve
significant cytokine production (Figure E1).
P. melaninogenica displayed an
intermediate but significant impact on IL-8
production. Upon stimulation of
16HBE14o2 cells with anaerobic
supernatants, only F. nucleatum induced
a significant IL-8 response compared
with baseline levels (Figure 2).
Furthermore, anaerobe-induced IL-8
responses in 16HBE14o2 cells were
strikingly lower than in CFBE41o2 cells,
suggesting that the CF epithelium is more
susceptible to stimulation by anaerobic
supernatants.
SCFAs Generate a Notable IL-8
Response in CF Epithelial Cells
To elucidate whether SCFAs in anaerobic
supernatants contribute to IL-8 secretion,
bronchial epithelial cells were treated with
SCFAs and analyzed for IL-8 secretion.
The influence of SCFAs on cell viability was
evaluated to exclude any SCFA-induced
cytotoxicity (Figure E3), and in the
following experiments the cells were
treated with nontoxic concentrations
of SCFAs. All SCFAs, apart from
2-methylbutyric acid, induced a significant
and a dose-dependent IL-8 response
from CFBE41o2 cells (Figure 3) with
the following potency in descending
order: butyric acid (half-maximal effective
concentration [EC50] = 0.170 mM; R
2 =
0.8816), i-valeric acid (EC50 = 1.0 mM; R
2 =
0.7711), propionic acid (EC50 = 4.6 mM;
R2 = 0.9107), acetic acid (EC50 = 15.5 mM;
R2 = 0.8443), i-butyric acid (EC50 = 64 mM;
R2 = 0.8304). At the same time, no basal
or SCFA-stimulated IL-1b levels were
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Figure 1. Anaerobic species are found in high numbers in the cystic fibrosis (CF) airways and
secrete copious amounts of short-chain fatty acids (SCFAs) in vitro and in vivo. (A) The
percentage of anaerobe-positive cultures in children with CF up to 6 years of age (n = 24; mean
age, 3.56 1.6 yr; 11 males and 13 females) and people with cystic fibrosis (PWCF) older than
7 years of age (n = 85; mean age, 25.66 8.9 yr; 54 males and 31 females). Sputum or
bronchoalveolar lavage (BAL) samples of 109 PWCF were collected and screened for the
presence of anaerobic bacteria as stated in the METHODS section. For the sake of clarity, only
four genera of the most frequent obligate anaerobes (Prevotella, Actinomyces, Veillonella, and
Fusobacterium) and the most commonly occurring aerobes (facultative anaerobes) belonging
to the genera Pseudomonas, Staphylococcus, and Streptococcus are shown. (B) SCFA levels
in bacterial supernatants from American Type Culture Collection (ATCC) and patient isolate
strains of Prevotella melaninogenica, Actinomyces odontolyticus, Veillonella parvula,
Fusobacterium nucleatum, and Streptococcus sanguinis as determined by gas
chromatography. Data are presented as mean6 SEM (n> 3). (C) SCFA levels in BAL
samples of children with CF (n = 7; mean age, 4.06 2.2 yr; 2 males and 5 females) and adults with
CF (n = 11; mean age, 29.26 9.3 yr; 3 males and 8 females). (D) IL-8 levels in BAL samples
of children with CF (n = 6; mean age, 4.56 1.9 yr; 2 males and 4 females) and adults with CF
(n = 10; mean age, 30.16 9.7 yr; 3 males and 7 females) as evaluated with an IL-8 ELISA.
(E) Correlation between IL-8 and acetic acid in BAL samples of PWCF (n = 16; r 2 = 0.6409;
P = 0.002). **P< 0.01; ***P< 0.001.
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not shown). Additionally, a small but
insignificant increase in SCFA-induced IL-6
over baseline was observed in CFBE41o2
supernatants (Figure E4). However, this
response was markedly lower than with
IL-8, confirming that IL-8 is the
predominant proinflammatory cytokine
induced by SCFAs in CF bronchial
epithelial cells. When CFBE41o2 cells were
treated with a combination of SCFAs
mimicking the complex SCFA secretomes
of P. melaninogenica, F. nucleatum, and
V. parvula, no synergistic effect on IL-8
secretion was observed (Figure E5). SCFAs
also induced a dose-dependent IL-8
response in 16HBE14o2 cells (Figure 3);
however, IL-8 secretion was significantly
less pronounced in 16HBE14o2 cells than
in CFBE41o2 cells, corroborating our
earlier observations with anaerobic
supernatants. These results confirm that
SCFAs in anaerobic supernatants are at
least in part responsible for the
inflammatory response in bronchial
epithelial cells in vitro.
Of note, upon incubation of
representative SCFAs (acetic, propionic,
and butyric acids) with human serum
albumin or a1-antitrypsin, no changes in
intrinsic fluorescence of either proteins
were observed (Figure E6), suggesting
that SCFAs do not bind human serum
albumin or a1-antitrypsin. Moreover, the
latter also failed to attenuate the SCFA-
induced IL-8 response in CFBE41o2 cells
(Figure E7).
SCFA-mediated Release of IL-8 by
CFBE41o2 Cells Is GPR41 Dependent
Previous studies have shown that GPR41
couples exclusively through the PTX-
sensitive Gai/o family, whereas GPR43
displays dual coupling through Gai/o and
PTX-insensitive Gaq protein families (24,
25). To explore whether SCFA-mediated
IL-8 release was indeed mediated by SCFA
receptors, CFBE41o2 cells were treated
with PTX before SCFAs. PTX (250 ng/ml)
significantly attenuated IL-8 secretion in
CFBE41o2 cells induced by all evaluated
SCFAs (Figure 4A). Higher PTX
concentrations (500 and 1,000 ng/ml) did
not fully restore the IL-8 baseline levels
(Figure E8). These data suggest the
involvement of PTX-sensitive receptors
GPR41 and GPR43 in SCFA-mediated
cytokine response in CFBE41o2 cells.
To further confirm the involvement
of GPR41 in SCFA-mediated IL-8
response, a small interfering RNA
(siRNA)–knockdown approach was
employed. siRNA (80 nM)-mediated
knockdown of GPR41 was confirmed
using reverse transcription polymerase
chain reaction and Western blot analysis
48 hours after transfection (Figure 4B and
4C). The reduction of GPR41 protein
expression (z50%), although not complete,
was sufficient to produce a significant
decrease in the IL-8 production induced by
acetic acid (10 mM), propionic acid
(1 mM), and butyric acid (1 mM)
(Figure 4D). Collectively, these data
corroborate the involvement of GPR41 in
SCFA-mediated IL-8 release by CF
bronchial epithelial cells.
GPR41 Expression Is Increased in CF
Compared with Normal Bronchial
Epithelial Cells
To confirm the expression of SCFA
receptors in human bronchial epithelium,
mRNA and protein levels of GPR41 and
GPR43 were evaluated. Western blot
analysis revealed that the GPR41 receptor
was expressed by both 16HBE14o2 and
CFBE41o2 cells, with significantly higher
protein expression in CFBE41o2 cells than
in 16HBE14o2 cells (P, 0.001)
(Figure 5A). GPR43 was expressed in
16HBE14o2 and CFBE41o2 cells at
equivalent levels (Figure 5A). The cell
surface expression of SCFA receptors
was further examined with laser scanning
cytometry and confocal microscopy.
Staining for the GPR41 receptor was
significantly increased on the surface
of CFBE41o2 cells compared with
16HBE14o2 cells as assessed with
laser scanning cytometry (55.56 19.5%;
P, 0.001) (Figure 5B). Although both
cell lines displayed intracellular staining
for GPR41 receptor as visualized with
confocal microscopy (Figure 5C), a













































































Figure 2. Supernatants from anaerobic bacteria promote a proinflammatory response in cystic fibrosis
airway epithelial cells. 16HBE14o2 and CFBE41o2 cells were treated with 5% bacterial supernatants
or growth medium as a control for 24 hours, and IL-8 secretion was assessed with an ELISA. All data
are presented as mean6 SEM of at least three independent experiments. **P< 0.01; ***P< 0.001.
The dotted line represents the normalized IL-8 production in the presence of control medium.
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the GPR41 receptor with the plasma
membrane marker Na1/K1-ATPase was
observed in CFBE41o2 cells (11.96 2.0%)
compared with 16HBE14o2 cells (6.96
1.1%, P = 0.0434). No differences in
GPR43 cell surface expression were
detected in 16HBE14o2 and CFBE41o2
cells when analyzed with laser
scanning cytometry or confocal
microscopy (Figure E9). These results
suggest that although GPR41 and
GPR43 are both present in bronchial
epithelial cells, only GPR41 is
up-regulated at the surface of CF
epithelial cells compared with normal
bronchial epithelial cells.
To investigate whether GPR41 mRNA
was also increased in CFBE41o2 cells,
quantitative reverse transcription
polymerase chain reaction was performed.
GPR41 mRNA levels were significantly
increased in CFBE41o2 compared with
16HBE14o2 cells (P, 0.001) (Figure 5D).
The in vitro trend was also observed in vivo
as an increase in GPR41 mRNA levels in
bronchial brushings from PWCF compared
with non-CF controls (P = 0.0064)
(Figure 5E).
Endoplasmic Reticulum Stress
Up-regulates GPR41 Expression in CF
Bronchial Epithelial Cells In Vitro
Previous studies have associated
dysfunctional CFTR with ER stress and
activation of the unfolded protein response
(UPR) (32). To elucidate whether the latter
could have an impact on GPR41
expression, 16HBE14o2 cells were treated
with tunicamycin (2 mg/ml) or thapsigargin
(2 mM), which are well-established
inducers of ER stress and UPR (33). ER
stress and UPR induction by these
compounds was confirmed by monitoring
the expression of glucose-regulated proteins
78 and 94 (Figure E10). Tunicamycin and
thapsigargin significantly increased
GPR41 protein levels in 16HBE14o2 cells
(P = 0.0297 and P = 0.0198, respectively)
(Figure 6A). These data suggest that ER
stress and UPR may have a role in
GPR41 up-regulation in CF bronchial
epithelial cells.
Dysfunctional CFTR and the
Inflammatory CF Environment
Promote GPR41 Up-regulation in CF
Bronchial Epithelial Cells In Vitro
To explore the possibility that GPR41
up-regulation in the CF airway epithelium
could also be associated with reduced
CFTR activity, 16HBE14o2 cells were
treated with a CFTR inhibitor, CFTR
(inh)-172 (10 mM), and subsequently
evaluated for GPR41 mRNA expression.
CFTR inhibition significantly increased
GPR41 mRNA levels in 16HBE14o2 cells
(P = 0.0166) (Figure 6B), matching them
to levels found in CFBE41o2 cells
(Figure 5). Similarly, 10% CF BAL caused
a significant up-regulation of GPR41
mRNA in 16HBE14o2 cells (P, 0.001)
(Figure 6B). These findings were translated
to the protein level, as both CFTR(inh)-172
and 10% CF BAL significantly elevated
GPR41 protein levels in 16HBE14o2 cells
(P = 0.0233 and P = 0.0098, respectively)
(Figure 6C). Similarly, GlyH-101, another
inhibitor of CFTR, also increased GPR41
protein levels (data not shown). These
results imply that reduced CFTR activity
may be associated with GPR41 up-
regulation in CF bronchial epithelial cells
in vitro, an effect that is also driven by the
inflammatory CF airway milieu.
Discussion
Recent advances in culture-independent
molecular techniques for bacterial
identification have sparked a renewed
interest in the role of anaerobic bacteria in
the CF airways. Therefore, we aimed to
explore the contribution of anaerobes via




























































































































































Figure 3. Short-chain fatty acids (SCFAs) induce a dose-dependent IL-8 response in bronchial
epithelial cells. 16HBE14o2 and CFBE41o2 cells were treated with increasing concentrations
of SCFAs for 24 hours and monitored for IL-8 production using an ELISA. All data are presented as
means6 SEM of at least three independent experiments. *P< 0.05; **P< 0.01; ***P< 0.001. The
dotted line represents the normalized IL-8 production in the presence of control medium.
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disease. In the present study, we show
that anaerobic bacteria commonly found
in the CF airways secrete SCFAs in vitro
and in vivo and, by acting through SCFA
receptors, mediate IL-8 release,
promoting an inflammatory response in
the CF airway.
Similarly to previous studies (7, 8, 16),
our cohort of PWCF displayed a high
prevalence of anaerobic bacteria (52.3%).
This number was greater than that of
P. aeruginosa (43.2%), an established CF
airway pathogen, confirming that anaerobes
are prevalent in the CF airways and may
play a role during the course of the disease.
Indeed, the percentage of PWCF positive
for anaerobes increased with their age.
Five representative species that were
selected on the basis of their prevalence,
secreted high quantities of SCFAs, with
each displaying a distinct SCFA secretome
(Figure 1B). SCFAs were also detected in
CF BAL and were elevated in BAL samples
of adult PWCF compared with children
with CF (Figure 1C). This suggests that,
alongside anaerobes, SCFAs also increase
with age. Although SCFAs were previously
studied in the context of allergic airway
inflammation (34), the present study is the
first, to our knowledge, to prove the
presence of SCFAs in the lower airways.
CF airway disease is characterized by an
exaggerated neutrophil influx that plays a
key role in tissue damage and disease
progression (35). We have previously
shown that IL-8, a potent neutrophil
chemotactic agent, is readily secreted
from CF airway epithelium by various
stimuli (36–38) and is found in high
concentrations in CF BAL (31).
Anaerobic supernatants induced a
potent and dose-dependent IL-8
response that was more pronounced in CF
than in normal bronchial epithelium
(Figure 2 and Figure E1). Similarly,
SCFAs generated a dose-dependent IL-8
response in bronchial epithelial cells that
was higher in CF than in normal
bronchial epithelial cells (Figure 3), suggesting
that SCFAs in anaerobic supernatants
contribute to the IL-8 response and may have
a detrimental role in the CF airways by
promoting neutrophil mobilization.
In addition to the activation of airway
epithelial cells to produce cytokines,
SCFAs are known to display a plethora of
other effects. SCFAs were recently shown
to act as chemotactic agents for neutrophils
































































































































































































































Figure 4. Pertussis toxin and GPR41 small interfering RNA (siRNA) attenuate short-chain fatty
acid (SCFA)-mediated IL-8 secretion in cystic fibrosis bronchial epithelial cells. (A) CFBE41o2 cells
were treated with pertussis toxin (PTX; 250 ng/ml) and increasing concentrations of SCFAs for 24
hours. Afterward, cell supernatants were monitored for IL-8 secretion using an ELISA. CFBE41o2
cells were transfected with GPR41 or control siRNA and were evaluated for GPR41 mRNA and
protein levels 48 hours after transfection using quantitative reverse transcription polymerase chain
reaction and Western blot analysis, respectively. (B) mRNA expression of GPR41 relative to
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was determined using the 22DDCt cycle
threshold method, and the results are presented as fold differences. (C) Whole cell lysates
were separated by 12.5% sodium dodecyl sulfate–polyacrylamide gel electrophoresis, transferred
to a polyvinylidene fluoride membrane, and detected with anti-GPR41 antibody. Signal intensities
of all bands were quantified by densitometry and normalized against GAPDH, which served as a
loading control. Bar graph depicts densitometric analysis of GPR41 expression. All data are
presented as means6 SEM (n> 3). (D) CFBE41o2 cells were transfected with GPR41 or control
siRNA (80 nM) 24 hours before treatment with acetic acid (10 mM), propionic acid (1 mM), and
butyric acid (1 mM) for an additional 24 hours. Cell supernatants were monitored for IL-8
secretion using an ELISA. The results shown are representative of three independent experiments.
*P< 0.05; **P< 0.01; ***P< 0.001.
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reported to impair neutrophil reactive
oxygen species production, phagocytosis,
and microbial killing (40). This suggests
that, in addition to IL-8-mediated
recruitment of neutrophils, SCFAs may
display a direct effect on neutrophil
migration to the CF airways and on
their function.
Both SCFA receptors, GPR41 and
GPR43, couple to the PTX-sensitive Gai/o
family of proteins, but only GPR43 also
couples to the PTX-insensitive Gaq family
of proteins (24, 25). PTX blocks the
signaling mediated by Gai/o proteins,
and PTX treatment significantly reduced
the SCFA-mediated IL-8 response
(Figure 4), confirming that SCFAs mediate
their effects via SCFA receptors GPR41 and
GPR43. However, increasing the
concentration of PTX did not return the
levels of IL-8 production to baseline after
stimulation by propionic and butyric acids
(Figure E8). Propionic and butyric acids are
well-established inhibitors of HDAC (41),
and previous studies have shown that
butyric acid induces an IL-8 response in
human intestinal epithelial cells by
inhibiting HDAC activity and promoting
histone acetylation (26). Therefore,
































































































































Figure 5. Short-chain fatty acid receptor GPR41 is upregulated at the surface of cystic fibrosis (CF) bronchial epithelial cells. (A) A
representative Western blot depicting GPR41 and GPR43 protein expression in 16HBE14o2 and CFBE41o2 cells. Whole cell lysates were
separated by 12.5% sodium dodecyl sulfate–polyacrylamide gel electrophoresis, transferred to a polyvinylidene fluoride membrane, and
detected with anti-GPR41 or anti-GPR43 antibody. Signal intensities of all bands were quantified by densitometry and normalized against
glyceraldehyde 3-phosphate dehydrogenase (GAPDH), which served as a loading control. Bar graph depicts densitometric analysis of
GPR41 expression in 16HBE14o2 and CFBE41o2 cells. Data are shown as means6 SEM (n> 3). (B) GPR41 cell surface staining was analyzed
in CFBE41o2 and 16HBE14o2 cells using laser scanning cytometry as stated in the METHODS section. Histograms representative of three
independent experiments are shown. Inset values represent fold increases in mean fluorescence intensity between cells stained with primary
anti-GPR41 and secondary antibody (black line) and control cells stained only with the secondary antibody (gray line). (C) 16HBE14o2 or
CFBE41o2 cells were grown on coverslips and probed with anti-GPR41 and anti-Na1/K1-ATPase antibody, respectively, followed by
fluorescein isothiocyanate (FITC)-labeled and Alexa Fluor 568 secondary antibody, respectively. Controls were labeled with secondary antibodies
only and are shown in Figure E11. Cell nuclei were visualized using 49,6-diamidino-2-phenylindole dihydrochloride (DAPI; blue), GPR41 and
Na1/K1-ATPase are represented as green and red fluorescence, and colocalization is shown in white. Images shown are representative of three
independent experiments. Scale bar, 5 mm. Quantitative reverse transcription polymerase chain reaction was performed (D) in vitro using
CFBE41o2 and 16HBE14o2 epithelial cells and (E) in vivo using bronchial brushings from people with cystic fibrosis (n = 3; mean age, 23.06 4.0
yr; 2 males and 1 female) and control subjects without CF (n = 3; mean age, 56.36 9.5 yr; 3 females). Expression of GPR41 relative to
GAPDH was determined using the 22DDCt cycle threshold method, and the results are presented as fold differences. Data are presented as
means 6 SEM (n> 3). **P< 0.01; ***P< 0.001.
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epithelial cells may also be mediated by
HDAC inhibition in addition to SCFA
receptors. Nevertheless, even a partial
reduction (z50%) of GPR41 protein
expression induced by siRNA silencing was
sufficient for significant inhibition of
SCFA-mediated IL-8 production
(Figure 4D), corroborating the role of
GPR41 in SCFA-mediated IL-8 release by
CF bronchial epithelial cells.
GPR41 expression is increased in CF
bronchial epithelium in vitro and in vivo
(Figure 5), and the mechanism of
up-regulation was subsequently
investigated. F508del-CFTR is the most
common cause of CF. It causes misfolding
of CFTR and its subsequent degradation
after synthesis, leading to a lack of the
functional CFTR on the cell surface (42).
Treatment with CFTR(inh)-172, a CFTR
inhibitor, increased mRNA and protein
levels of GPR41 in 16HBE14o2 cells
(Figure 6B and 6C), suggesting that the lack
of CFTR activity could be associated with
GPR41 up-regulation in CF bronchial
epithelial cells and that the mechanism
could be related to defective chloride ion
and/or bicarbonate conductance.
Previously, we demonstrated altered
expression of microRNAs (miRNAs) in CF
(30). miR-182, miR-23b, and miR-544 were
shown to be decreased in CF bronchial
brushings (30), and we identified them as
targeting GPR41 mRNA by using various
miRNA target prediction databases (43,
44). However, overexpression of these
miRNAs failed to reduce GPR41 mRNA
and protein expression in CFBE41o2 cells
(data not shown), excluding the possibility
of regulation of GPR41 expression by these
miRNAs. Accumulation of misfolded
F508del-CFTR in the ER causes ER stress
that activates UPR, a signal transduction
pathway to alleviate this stress and restore
ER homeostasis (32, 45, 46). Exposure of
16HBE14o2 cells to tunicamycin or
thapsigargin, well-known inducers of ER
stress and UPR, increased protein
expression of GPR41 (Figure 6A), implying
that the ER stress and UPR may also,
independent of CFTR activity, contribute to
GPR41 up-regulation. The CF airway also
harbors high concentrations of
proinflammatory markers, including
proteases and chemokines (31). Treatment
of 16HBE14o2 cells with CF BAL increased
GPR41 mRNA and protein levels
(Figure 6B and 6C), suggesting that, in
addition to intrinsic up-regulation of
GPR41 in CF, the latter could further be
corroborated by the inflammatory milieu
of the CF airways.
In conclusion, we propose a novel
mechanism by which anaerobic bacteria,
through the production of SCFAs,
contribute to the inflammatory
environment in the CF airways, in this way
potentially amplifying mobilization of
neutrophils, tissue destruction, and disease
progression. These data suggest that
eradication of anaerobes in PWCF may be
beneficial by resolving the excessive
inflammation brought on by these
microorganisms. n
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